Recipient Title Vice President of Operations, Revlon Group Holdings, LLC, 1501 Williamsboro St. Oxford , NC 27565 United StatesFEI 1021184Issued Jun 2, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 1021184.
Violations4
Issue DateJun 2, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Revlon Group Holdings, LLC
Location
Recipient Title Vice President of Operations, Revlon Group Holdings, LLC, 1501 Williamsboro St. Oxford , NC 27565 United States
FEI Number
1021184
Country
United States
Issue Date
June 02, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/OTC Finished Pharmaceuticals/Adulterated
Revlon Group Holdings, LLC FDA Warning Letter, June 2, 2026
Talk to a Specialist